Anti-EYS/ C6orf178/ C6orf179 functional antibody

Anti-EYS/ C6orf178/ C6orf179 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to EYS/EYS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0910-Ab-1/ GM-Tg-hg-SE0910-Ab-2Anti-Human EYS monoclonal antibodyHuman
GM-Tg-rg-SE0910-Ab-1/ GM-Tg-rg-SE0910-Ab-2Anti-Rat EYS monoclonal antibodyRat
GM-Tg-mg-SE0910-Ab-1/ GM-Tg-mg-SE0910-Ab-2Anti-Mouse EYS monoclonal antibodyMouse
GM-Tg-cynog-SE0910-Ab-1/ GM-Tg-cynog-SE0910-Ab-2Anti-Cynomolgus/ Rhesus macaque EYS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0910-Ab-1/ GM-Tg-felg-SE0910-Ab-2Anti-Feline EYS monoclonal antibodyFeline
GM-Tg-cang-SE0910-Ab-1/ GM-Tg-cang-SE0910-Ab-2Anti-Canine EYS monoclonal antibodyCanine
GM-Tg-bovg-SE0910-Ab-1/ GM-Tg-bovg-SE0910-Ab-2Anti-Bovine EYS monoclonal antibodyBovine
GM-Tg-equg-SE0910-Ab-1/ GM-Tg-equg-SE0910-Ab-2Anti-Equine EYS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0910-Ab-1/ GM-Tg-hg-SE0910-Ab-2; GM-Tg-rg-SE0910-Ab-1/ GM-Tg-rg-SE0910-Ab-2;
GM-Tg-mg-SE0910-Ab-1/ GM-Tg-mg-SE0910-Ab-2; GM-Tg-cynog-SE0910-Ab-1/ GM-Tg-cynog-SE0910-Ab-2;
GM-Tg-felg-SE0910-Ab-1/ GM-Tg-felg-SE0910-Ab-2; GM-Tg-cang-SE0910-Ab-1/ GM-Tg-cang-SE0910-Ab-2;
GM-Tg-bovg-SE0910-Ab-1/ GM-Tg-bovg-SE0910-Ab-2; GM-Tg-equg-SE0910-Ab-1/ GM-Tg-equg-SE0910-Ab-2
Products NameAnti-EYS monoclonal antibody
Formatmab
Target NameEYS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EYS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0910-Ag-1Recombinant multi-species EYS/ C6orf178/ C6orf179 protein


    Target information

    Target IDGM-SE0910
    Target NameEYS
    Gene ID346007,100070526
    Gene Symbol and SynonymsbA166P24.2,bA307F22.3,bA74E24.1,C6orf178,C6orf179,C6orf180,dJ1018A4.2,dJ22I17.2,dJ303F19.1,EGFL10,EGFL11,EYS,RP25,SPAM
    Uniprot AccessionQ5T1H1
    Uniprot Entry NameEYS_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188107
    Target ClassificationN/A

    The target: EYS, gene name: EYS, also named as C6orf178, C6orf179, C6orf180, EGFL10, EGFL11, RP25, SPAM, bA166P24.2, bA307F22.3, bA74E24.1, dJ1018A4.2, dJ22I17.2, dJ303F19.1. The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.